Register
Biologic Therapy Tied to Less Coronary Inflammation in Psoriasis |
Journal Updates
eMediNexus Coverage from: 
Biologic Therapy Tied to Less Coronary Inflammation in Psoriasis
eMediNexus,  11 August 2019
remove_red_eye 485 Views
#Business And Medicine #Cardiology #Dermatology #Pathology and Lab Medicine

0 Read Comments                

Anti-inflammatory biologic therapies are associated with reduced coronary inflammation in patients with psoriasis, a new study suggests.Investigators noted that after 1 year, the perivascular fat index (FAI) — a novel imaging biomarker that assesses coronary inflammation, measured by coronary computed tomography angiography (CCTA) — was significantly lower in patients treated with biologic therapies than in those in the control group, independent of the presence of coronary plaque. The findings are published online in JAMA Cardiology.

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now